Company and Leadership
What are the benefits for inventors and universities in working with VIC Foundry?
The VIC Foundry team has extensive technology commercialization experience and success. Working with our team can help steer technology development in the most impactful and commercially-promising directions. Access to SBIR and STTR funding is provided without the inventor needing to form a separate new company, which is time-consuming, distracting from the university research, while carrying significant costs and risks.
When the grant-funded development work goes as planned, a new company is formed to commercialize the technology with private equity funding ensured. VIC has a strong track record for successfully commercializing university technologies. The inventor takes a technical advisor role in the new company and can receive equity and consulting compensation.
For universities, it is an opportunity for licensing technologies that otherwise may never be licensed due to the stage of development at the university. Universities can benefit from subcontracted work back to the university, and from having a much higher chance of substantial licensing revenue compared to a typical faculty or student-led startup.
What are the benefits for investors?
For the VIC Investor network, the VIC Foundry provides an additional source of high-quality deal flow and de-risks highly promising technologies. It allows deeper insights prior to VIC making the go/no-go decision on a new start-up to commercialize the given technology.
Calvin Goforth, PhD – Chief Executive Officer
Xiaoli Su, PhD – Senior Scientist
Evan Goldberg, PhD – Senior Fellow
Cristhiaan Ochoa, MD, PhD – Senior Fellow
Cristhiaan Ochoa is a staff Pulmonary and Critical Care physician at JPS Health and a Clinical Assistant Professor of Medicine at U.T. Southwestern Medical Center in Dallas, TX. With over 20 peer-reviewed publications and two patents pending, he is passionate about medical research and innovation. He holds an M.D. from Universidad Pontificia Bolivariana in his native country of Colombia and a Ph.D. from the University of South Alabama Center for Lung Biology. He did his postdoctoral training at Massachusetts General Hospital and Harvard Medical School. His research has been funded by the National Institutes of Health (NHLBI and NCI) and the American Heart Association. Cristhiaan is also a medical officer in the U.S. Air Force Reserve.
Alexandra Antonioli, MD, PhD – Fellow
Alexandra H. Antonioli, MD, PhD, received a BS in Biophysics and Biochemistry from Yale University. She then joined the Medical Scientist Training Program (MSTP) at the University of Colorado and received her combined MD and PhD degrees. Her thesis research and brief postdoctoral work focused on combining structural biology with translational immunology experiments to better understand mechanisms that drive inflammation and autoimmunity. In addition to continually trying to improve and develop her clinical skills and medical knowledge base, Alexandra has a passion for volunteer work and has spent time volunteering in Yamoransa, Ghana with the Yale Alumni Service Corps. Alexandra is also a Rotarian and in 2014 was honored with the Thomas Jefferson Award for service to the University of Colorado. She has also completed a medical journalism elective at ABC News in New York City. Alexandra believes that forming collaborations in science, medicine, media, and technology serve as important keys to making advances within any field and hopes to continue a combination of medicine, science and service throughout her career. Dr. Antonioli is currently a PGY4 resident and member of the Psychiatry Research Track at the University of Texas Southwestern Medical Center.
Danielle France, PhD – Fellow
Danielle France is a scientist and biotech entrepreneur fascinated by emerging biotechnologies and their path to meaningful impact. As a researcher she looked for details that make or break an experiment or a new technology. As an entrepreneur she brought technology out of the lab and onto the path to market. She can ask the tough questions that determine if it’s time to take that first brave step on the path to commercialization.
During 15 years in biophysics and microbiology research, Danielle worked with a sustainable energy startup in microbial coal methanogenesis, showed the potential of “material probiotics” for preventing steel corrosion, and invented a new technology for sensing nanomechanical movements of bacteria. That technology formed the basis of a company pursuing a 2-hour phenotypic antimicrobial susceptibility test for urinary tract infections. In her role as co-founder and CEO, Danielle combined business development with her hands-on expertise in wet lab microbiology, data acquisition, and data analysis in order to drive technology development. Danielle holds a BS in biomedical engineering from Washington University in St. Louis and a PhD in biological engineering from MIT.
Mark Jarboe, MBA – Fellow
Mark Jarboe has spent his entire career, with innovative healthcare companies. Mark is experienced in comprehensive start-up business operations including business development, strategic partnerships, customer discovery, and product development.
Currently, Mark is COO of Health Connect South, who’s mission is to bring together executives, researchers, and entrepreneurs from across the Southeast to share ideas as well as be a platform for strategic collaborations and partnerships. In addition to Health Connect South, he also serves on several advisory boards and consults with early-stage companies. Mark is a proud alumni of Leadership Georgia and recently served on Lt Governor Geoff Duncan’s Innovation Task Force, to help make Georgia the “Innovation Capital of the East”.
Mark holds a bachelor’s degree in Political Science from Miami University in Oxford, Ohio as well as an MBA with an emphasis on international business from Georgia State University.
Matthew Leming, PhD – Fellow
Matthew Leming is a former bench scientist who now serves as a strategic advisor for healthcare focused startup companies. He has 10 years of experience in basic science research with 10 peer reviewed publications in journals ranging from BMC Genomics, Journal of Neuroscience, and Scientific Reports. This is complimented by more than six years of direct healthcare focused startup project management and technology transfer experience. This experience was gained at the University of Notre Dame where he received his PhD in Biology, the University of Pittsburgh Medical Center, where he did his postdoctoral training and worked in tech transfer, and, most recently, the Texas Medical Center Accelerator, a program that is rated silver by the Accelerator Seed Rankings Project. Along the process he has had the opportunity to sit on every side of the entrepreneurial table. Matthew has a breadth of experience in commercialization projects ranging from academic to commercial translation, mobile health platforms, medical devices, and drug discovery. His passion truly lies in the commercialization of medical innovations.
Ronald Walls, MD, MBA – Fellow
Walls attended medical school at Drexel College of Medicine and did his residency at U.C. Davis Medical Center and a fellowship in Surgical Oncology at the National Cancer Institute at the National Institutes of Health. In 1999, Walls decided to pursue a career in the biopharmaceutical industry. To understand both the commercial and medical sides of the industry, in 2006, he received his MBA from Lake Forest Graduate School of Business. This experience exposed him to the Healthcare/ Life Science venture capital industry.